Enzyme insight could lead to new diabetes treatment

Credit: CC0 Public Domain

Research led by the Centenary Institute has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 (SphK2) results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.

The findings raises the possibility of a…

Read Entire Article Here…

Leave a Reply

Your email address will not be published. Required fields are marked *